|
Post by magnus123 on Feb 19, 2022 12:30:04 GMT
OPTN recovered nicely from this desaster. Completely changed stock since the offering. Unbelievable what happened here. Biotech mafia was in full force. Now with the 2 study readouts coming, the first one anyday, I'm not sure what to do. A fail will send us back to 1.50 or below... Succesful readouts should move it at least to $4-5 in my opinion. Given the fact that studies against Nasal Polyps were succesful and good enough to receive FDA approval I'd lean towards a succesful readout. If studies are succesful, I'd expect a buyout later this year instead of a primary care partnership.
|
|
|
Post by magnus123 on Mar 7, 2022 12:04:42 GMT
|
|
|
Post by magnus123 on Jun 13, 2022 16:45:45 GMT
|
|
|
Post by JHam on Jun 13, 2022 17:03:40 GMT
Wow. Amazing to see that a stock can still jump 40% in this market.
|
|
|
Post by magnus123 on Jun 13, 2022 18:18:07 GMT
Wow. Amazing to see that a stock can still jump 40% in this market. A huge surprise indeed. Typically in this market is that it opens 30% higher and flips into red within the first 15 mins.
|
|
|
Post by magnus123 on Jun 15, 2022 15:16:45 GMT
OPTN still surging higher. $3.21 right now. Buyout or big partnership coming?
|
|
|
Post by magnus123 on Jun 15, 2022 15:20:36 GMT
I can't believe that it's rising just because the data is good. There was a sell off 99% of the times after a company announced positive data in the past 6-9 months.
|
|